[1. Boggs R.M., Moody J.A., Long C.R., Tsai K.L., Murphy K.E.: Identification, amplification and characterization of miR-17-92 from canine tissue. Gene 2007, 404, 25-30.10.1016/j.gene.2007.08.01517904311]Search in Google Scholar
[2. Boggs R.M, Wright Z.M, Stickney M.J., Porter W.W., Murphy K. E. MicroRNA expression in canine mammary cancer. Mamm Genome 2008, 19, 561-569.10.1007/s00335-008-9128-718665421]Search in Google Scholar
[3. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., Shimizu M., Cimmino A., Zupo S., Dono M., Dell’Aquila M.L., Alder H., Rassenti L., Kipps T.J., Bullrich F., Negrini M., Croce C.M.: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004, 101, 11755-11760.10.1073/pnas.040443210151104815284443]Search in Google Scholar
[4. Von Deetzen C., Schmeck B.T., Gruber A.D., Klopfleisch R.: Malignancy associated microRNA expression changes in canine mammary cancer of different malignancies. ISRN Vet Sci 2014:148597. doi: 10.1155/2014/148597.10.1155/2014/148597406055425002976]Search in Google Scholar
[5. Fenger J.M., Bear M.D., Volina S., Tzu-Yin L., Harrington B.K., London C.A., Kisseberth W.C.: Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. BMC Cancer 2014, 14-84.10.1186/1471-2407-14-84393348124517413]Search in Google Scholar
[6. Genini S., Guziewicz K.E., Beltran W.A., Aguirre G.D.: Altered miRNA expression in canine retinas during normal development and in models of retinal degeneration. BMC Genomics 2014, 15, 172.10.1186/1471-2164-15-172402913324581223]Search in Google Scholar
[7. Lewis B.P, Burge C.B., Bartel D.P.: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120, 15-20.10.1016/j.cell.2004.12.03515652477]Search in Google Scholar
[8. Li L., Yuan L., Luo J., Gao J., Guo J., Xie X.: Mi-R34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med 2013, 13, 109-117.10.1007/s10238-012-0186-522623155]Search in Google Scholar
[9. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R.: MicroRNA expression profiles classify human cancers. Nature. 2005, 435, 834-838.]Search in Google Scholar
[10. Ma L., Teruya-Feldstein J., Weinberg R.A.: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449, 682-688.10.1038/nature0617417898713]Search in Google Scholar
[11. Miller T.E., Ghoshal K., Ramaswamy B., Roy S., Datta J., Shapiro C.L., Jacob S., Majumder S.: MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 2008, 283, 29897-29903.10.1074/jbc.M804612200257306318708351]Search in Google Scholar
[12. Min H., Yoon S.: Got target? Computational methods for microRNA target prediction and their extension. Exp Mol Med 2010, 42, 233-244.10.3858/emm.2010.42.4.032285932320177143]Search in Google Scholar
[13. Noguchi S., Mori T., Hoshino Y., Yamada N., Nakagawa T., Sasaki N., Akao Y., Maruo K.: Comparative study of anti-oncogenic microRNA-145 in canine and human malignant melanoma. J Vet Med Sci 2012, 74, 1 -8.10.1292/jvms.11-026421836381]Search in Google Scholar
[14. O’Day E., Lal A.: MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res Treat 2010, 12, 201.10.1186/bcr2484287955920346098]Search in Google Scholar
[15. Ortholan C., Puissegur M.P., Ilie M., Barbry P., Mari B., Hofman P.: MicroRNAs and lung cancer: new oncogenes and tumour supressors, new prognosis factors and potential therapeutic targets. Curr Med Chem 2009, 16, 1047-1061.10.2174/09298670978758183319275611]Search in Google Scholar
[16. Peres-Rivas L.G., Jerez J.M., Carmona R., de Luque V., Vicioso L., Claros M.G., Viguera E., Pajares B., Sanchez A., Ribelles N., Alba E., Lozano J.: A microRNA signature associated with early recurrence in breast cancer. PLoS One 2014, 9, e91884.10.1371/journal.pone.0091884395483524632820]Search in Google Scholar
[17. Porkka K.P., Pfeiffer M.J., Waltering K.K., Vessella R.L., Tammela T.L., Visakorpi T.: MicroRNA expression profiling in prostate cancer. Cancer Res 2007, 67, 6130-6135.10.1158/0008-5472.CAN-07-053317616669]Search in Google Scholar
[18. Shi M., Liu D., Duan H., Shen B., Guo N.: Metastasis-related miRNAs, active players in breast cancer invasion and metastasis. Cancer Metastasis Rev 2010, 29, 785-799.10.1007/s10555-010-9265-920938719]Search in Google Scholar
[19. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., Massaque J.: Endogenous human microRNAs that supress breast cancer metastasis. Nature 2008, 451, 147-152.10.1038/nature06487278249118185580]Search in Google Scholar
[20. Uhl E., Krimer P., Schliekelman P., Tampkins S.M., Suter S.: Identification of altered microRNA expression in canine lymphoid cell lines and cases of B- and T- cell lymphomas. Genes Chromosomes Cancer 2011, 50, 950-967.10.1002/gcc.2091721910161]Search in Google Scholar
[21. Valastyan S., Reinhardt F., Benaich N., Caloqrias D., Szasz A.M., Wang Z.C., Brock J.E., Richardson A.L., Weinberg R.A.: A pleyotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137, 1032-1046.10.1016/j.cell.2009.03.047276660919524507]Search in Google Scholar
[22. Vinall R.L, Kent M.S, deVere White R.W.: Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, ortransitional cell carcinoma. Am J Vet Res 2012, 73, 1626-1633.10.2460/ajvr.73.10.162623013190]Search in Google Scholar
[23. Volina S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M.: A microRNA expression signature of human solid tumours defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103, 2257-2261.10.1073/pnas.0510565103141371816461460]Search in Google Scholar
[24. Wang Z., Liao H., Deng Z., Yang P., Du N., Zhanng Y., Ren H.: miRNA-205 affects infiltration and metastasis of breast cancer. Biochem Biophys Res Commun 2013, 441, 139-143.10.1016/j.bbrc.2013.10.02524129185]Search in Google Scholar
[25. Winter J., Diedrich S.: MicroRNA Biogenesis and cancer. Meth Mol Biol 2011, 676, 3-22.10.1007/978-1-60761-863-8_120931386]Search in Google Scholar
[26. Yan L.X., Huang X.F., Shao Q., Huang M.Y., Deng L., Wu Q.L., Zeng Y.X., Shao J.Y.: MicroRNA miR-21 overexpression in human breast cancer is associated with advancer clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008, 14, 2348-2360.10.1261/rna.1034808257886518812439]Search in Google Scholar
[27. Yang S., Li Y., Zhang T., Li S., Luo A., Chen H., Ding F., Wang X., Liu Z.: MicroRNA-34 supresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene. 2012, 32, 4294-4303.]Search in Google Scholar
[28. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., Song E.: Let-7 regulates self-renewal and tumourigenicity of breast cancer cells. Cell 2007, 131, 1109-1123.10.1016/j.cell.2007.10.05418083101]Search in Google Scholar
[29. Yu Z., Baserga R., Chen L., Wang C., Lisanti M.P., Pestell R.G.: MicroRNA, cell cycle, and human breast cancer. Am J Pathol 2010, 176, 1058-1064.10.2353/ajpath.2010.090664283212520075198]Search in Google Scholar
[30. Zhang B., Pan X., Cobb G.P., Anderson T.A.: MicroRNAs as oncogenes and tumour suppressors. Dev Biol 2007, 302, 1 -12.10.1016/j.ydbio.2006.08.02816989803]Search in Google Scholar